|
- A Case For Sexual Transmission of HCV: is there a higher risk among men who have sex with men? - (8/30/02)
 
- Liver & Kidney Transplants in HIV: selected HIV-related abstracts from Intl Congress on Transplantation Conference, Aug 25-30, 2002, Miami, FL. - (8/30/02)
 
- Liver & Lidney Transplants in HIV: New Research at Intl Congress on Transplantation Society - (8/30/02)
 
- Women With Impaired Glucose Tolerance During Pregnancy Have Significantly Poor Pregnancy Outcomes - (8/27/02)
 
- Depression & Anxiety Can Occur in Diabetics and Their Partners, Particularly Women - (8/27/02)
 
- Sperm Washing for Pregnancy in HIV - (8/27/02)
 
- New PI Boosted Regimen: Saquinavir/ritonavir - (8/25/02)
 
- High Risk for HIV Transmission in Black Men Who Have Sex With Men, and White MSM - (8/23/02)
 
- Roche and Trimeris Open Physician Enrollment For Fuzeon(TM) U.S. Early Access Program - (8/19/02)
 
- Diabetes, Insulin Resistance, Belly Fat Gain in HIV - (8/19/02)
 
- Erectile Dysfunction and Hepatitis C Virus Infection - (8/14/02)
 
- Trends in Transmission of Drug Resistant HIV - (8/13/02)
 
- Another Lackluster Study on Predicting Response to HAART by CD4 - (8/12/02)
 
- FRAM Study and Lipodystrophy: lipodystrophy study presented at Barcelona and an interview with the study author Carl Grunfeld - (8/9/02)
 
- Hepatitis C Antiviral Resistance in African-Americans (only for HIV- patients) - (8/9/02)
 
- Barcelona - Kaletra Studies at Barcelona - (8/8/02)
 
- Barcelona - XIVth International AIDS Conference, Barcelona, Spain - written by David Margolis, MD, University of
Texas - (8/8/02)
 
- ROCHE FREEZES HIV DRUG PRICES - (8/8/02)
 
- Barcelona - Study Finds Increase in AST After starting ART Increases Risk For death More Than Having HCV - (8/5/02)
 
- Nuke Sparing Regimen: Kaletra + 1000 mg Saquinavir - (8/12/02)
 
- Risks of Treatment Interruptions: a fully informed decision - (8/5/02)
 
- Barcelona - Hepatitis Highlights from Intl AIDS Conference Barcelona - (8/1/02)
 
- Barcelona - Retrospective analysis of the use of Tenofovir DF in a private practice - (8/1/02)
 
|